CJC-1295 is a synthetic GHRH (growth-hormone-releasing hormone) analog studied as a growth hormone secretagogue. It is offered here in two research forms: with DAC (Drug Affinity Complex, long-acting) and without DAC (Mod-GRF 1-29, short-acting). In laboratory research it is frequently paired with the selective ghrelin-receptor agonist Ipamorelin — or studied as a ready-made CJC-1295 + Ipamorelin blend — because the two stimulate GH release through complementary receptor pathways. New to these compounds? Read the primer on CJC-1295 and Ipamorelin. All items in this category are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.